Immunohistochemical detection of cancer stem cell related markers CD44 and CD133 in metastatic colorectal cancer patients

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Pitule, Pavel ^a   Cedikova, Miroslava ^a   Daum, Ondrej ^a   Vojtisek, Jan ^a   Vycital, Ondrej ^a   Hosek, Petr ^a   Treska, Vladislav ^a   Hes, Ondrej ^a   Kralickova, Milena ^a   Liska, Vaclav ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; HERMES ANTIGEN; CD44 PROTEIN, HUMAN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; TUMOR MARKER;

ADULT; ARTICLE; CANCER STEM CELL; CANCER SURVIVAL; DISEASE FREE INTERVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; MIDDLE AGED; OVERALL SURVIVAL; PROTEIN EXPRESSION; COLORECTAL TUMOR; KAPLAN MEIER METHOD; LIVER TUMOR; METABOLISM; PATHOLOGY; SECONDARY;

ANTIGENS, CD; ANTIGENS, CD44; COLORECTAL NEOPLASMS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; PEPTIDES; TUMOR MARKERS, BIOLOGICAL;

EID: 84901269327     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/432139     Document Type: Article

References (24)

1. Bonnet D., Dick J. E., Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine 1997 3 7 730 737 2-s2.0-0030789242 10.1038/nm0797-730 (Pubitemid 27298715)
2. Al-Hajj M., Wicha M. S., Benito-Hernandez A., Morrison S. J., Clarke M. F., Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 2003 100 7 3983 3988 2-s2.0-0037388204 10.1073/pnas.0530291100 (Pubitemid 36418143)
3. Collins A. T., Berry P. A., Hyde C., Stower M. J., Maitland N. J., Prospective identification of tumorigenic prostate cancer stem cells. Cancer Research 2005 65 23 10946 10951 2-s2.0-28244472369 10.1158/0008-5472.CAN-05-2018 (Pubitemid 41713363)
4. Ricci-Vitiani L., Lombardi D. G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De Maria R., Identification and expansion of human colon-cancer-initiating cells. Nature 2007 445 7123 111 115 2-s2.0-33846095137 10.1038/nature05384 (Pubitemid 46067311)
5. O'Brien C. A., Pollett A., Gallinger S., Dick J. E., A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007 445 7123 106 110 2-s2.0-33846100356 10.1038/nature05372 (Pubitemid 46067310)
6. Li C., Heidt D. G., Dalerba P., Burant C. F., Zhang L., Adsay V., Wicha M., Clarke M. F., Simeone D. M., Identification of pancreatic cancer stem cells. Cancer Research 2007 67 3 1030 1037 2-s2.0-33847052127 10.1158/0008-5472.CAN- 06-2030
7. Gottschling S., Schnabel P. A., Herth F. J. F., Herpel E., Are we missing the target? Cancer stem cells and drug resistance in non-small cell lung cancer. Cancer Genomics Proteomics 2012 9 5 275 286
8. Aguilar-Gallardo C., Simón C., Cells, stem cells, and cancer stem cells. Seminars in Reproductive Medicine 2013 31 1 5 13
9. Ishii H., Iwatsuki M., Ieta K., Ohta D., Haraguchi N., Mimori K., Mori M., Cancer stem cells and chemoradiation resistance. Cancer Science 2008 99 10 1871 1877 2-s2.0-54949117172 10.1111/j.1349-7006.2008.00914.x
10. Friedman M. D., Jeevan D. S., Tobias M., Murali R., Jhanwar-Uniyal M., Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid. Oncology Reports 2013 30 4 1645 1650
11. Dalerba P., Dylla S. J., Park I.-K., Liu R., Wang X., Cho R. W., Hoey T., Gurney A., Huang E. H., Simeone D. M., Shelton A. A., Parmiani G., Castelli C., Clarke M. F., Phenotypic characterization of human colorectal cancer stem cells. Proceedings of the National Academy of Sciences of the United States of America 2007 104 24 10158 10163 2-s2.0-34547193404 10.1073/pnas.0703478104 (Pubitemid 47175279)
12. Vermeulen L., Todaro M., De Sousa Mello F., Sprick M. R., Kemper K., Perez Alea M., Richel D. J., Stassi G., Medema J. P., Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proceedings of the National Academy of Sciences of the United States of America 2008 105 36 13427 13432 2-s2.0-51649111430 10.1073/pnas.0805706105
13. Huang E. H., Hynes M. J., Zhang T., Ginestier C., Dontu G., Appelman H., Fields J. Z., Wicha M. S., Boman B. M., Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Research 2009 69 8 3382 3389 2-s2.0-65949112714 10.1158/0008-5472.CAN-08-4418
14. - metastatic colon cancer cells initiate tumors. Journal of Clinical Investigation 2008 118 6 2111 2120 2-s2.0-45749102020 10.1172/JCI34401 (Pubitemid 351872330)
15. + lymphocytes as independent prognostic factors after radical surgical treatment. Anticancer Research 2012 32 5 2129 2132
16. Ren F., Sheng W. Q., Du X., CD133: a cancer stem cells marker, is used in colorectal cancers. World Journal of Gastroenterology 2013 19 17 2603 2611
17. Galizia G., Gemei M., Del Vecchio L., Zamboli A., Di Noto R., Mirabelli P., Salvatore F., Castellano P., Orditura M., De Vita F., Pinto M., Pignatelli C., Lieto E., Combined CD133/CD44 expression as a prognostic indicator of disease-free survival in patients with colorectal cancer. Archives of Surgery 2012 147 1 18 24 2-s2.0-84855992616 10.1001/archsurg.2011.795
18. Li X. D., Ji M., Wu J., Jiang J. T., Wu C. P., Clinical significance of CD44 variants expression in colorectal cancer. Tumori 2013 99 1 88 92
19. Langan R. C., Mullinax J. E., Ray S., Raiji M. T., Schaub N., Xin H. W., Koizumi T., Steinberg S. M., Anderson A., Wiegand G., Butcher D., Anver M., Bilchik A. J., Stojadinovic A., Rudloff U., Avital I., A pilot study assessing the potential role of non-CD133 colorectal cancer stem cells as biomarkers. Journal of Cancer 2012 3 231 240
20. Kemper K., Sprick M. R., De Bree M., Scopelliti A., Vermeulen L., Hoek M., Zeilstra J., Pals S. T., Mehmet H., Stassi G., Medema J. P., The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Research 2010 70 2 719 729 2-s2.0-76549120193 10.1158/0008-5472.CAN-09-1820
21. Liao Y., Hu X., Huang X., He C., Quantitative analyses of CD133 expression facilitate researches on tumor stem cells. Biological and Pharmaceutical Bulletin 2010 33 5 738 742 2-s2.0-77952400172 10.1248/bpb.33.738
22. Chen S., Song X., Chen Z., Li X., Li M., Liu H., Li J., CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis. PLoS ONE 2013 8 2 e56380
23. Horst D., Kriegl L., Engel J., Kirchner T., Jung A., CD133 expression is an independent prognostic marker for low survival in colorectal cancer. British Journal of Cancer 2008 99 8 1285 1289 2-s2.0-53849134099 10.1038/sj.bjc.6604664
24. - cells isolated from human colorectal cancer. Journal of Cancer Research and Therapeutics 2012 8 3 399 403